Real-Time News (current) FIRE NOW SIP Calculators
Easy-to-understand Financial Insights
that build Wealth.
Suit Of Products

Dr. Reddy’s to Introduce Vonoprazan Tablets in India for Gastrointestinal Disorders

July 18, 2024, 5:40 p.m.
  • Dr. Reddy’s Laboratories has signed a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company.
  • The agreement allows Dr. Reddy’s to commercialise Vonoprazan tablets…

Unlock the Full Filing And Lot More

Access premium insights and stay ahead of the market with Dzambhala Pro.

Learn More
DRREDDY Corporate Action
DRREDDY PRIOR FILINGS
ALL LATEST FILINGS